Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Pyridostigmine
Therapeutic Area : Immunology
Study Phase : Approved FDF
Sponsor : Milla Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
A.forall Announces Launch of a Generic Version of Pyridostigmine Bromide Syrup
Details : Pyridostigmine Bromide, generic version of Mestinon, is a cholinesterase inhibitor small molecule drug administered orally as a syrup for myasthenia gravis.
Product Name : Mestinon-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 12, 2023
Lead Product(s) : Pyridostigmine
Therapeutic Area : Immunology
Highest Development Status : Approved FDF
Sponsor : Milla Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable